Hmm.. I’d have to think more carefully about it. Was very much off-the-cuff. I mostly agree with your criticism, I think I was mainly thinking bio-risk makes most sense as a near-termist priority and so would get most of x-risk funding until solved, since it is much more tractable than AI Risk.
Maybe this is the main point I’m trying to make, and so the spirit of the post seems off, since near-termist x-risky stuff would mostly fund bio-risk and long-termist x-risky stuff would mostly go to AI.
Hmm.. I’d have to think more carefully about it. Was very much off-the-cuff. I mostly agree with your criticism, I think I was mainly thinking bio-risk makes most sense as a near-termist priority and so would get most of x-risk funding until solved, since it is much more tractable than AI Risk.
Maybe this is the main point I’m trying to make, and so the spirit of the post seems off, since near-termist x-risky stuff would mostly fund bio-risk and long-termist x-risky stuff would mostly go to AI.